(Q36830662)

16 August 2017

Risk factors for recurrence of ovarian borderline tumors (English)

1 reference

16 August 2017

J Huh

3

0 references

author name string

K K Shih

1

1 reference

16 August 2017

Q Zhou

2

1 reference

16 August 2017

J C Morgan

4

1 reference

16 August 2017

A Iasonos

5

1 reference

16 August 2017

C Aghajanian

6

1 reference

16 August 2017

D S Chi

7

1 reference

16 August 2017

R R Barakat

8

1 reference

16 August 2017

N R Abu-Rustum

9

1 reference

16 August 2017

language of work or name

English

0 references

publication date

10 December 2010

1 reference

16 August 2017

1 reference

16 August 2017

120

1 reference

16 August 2017

3

1 reference

16 August 2017

480-484

1 reference

Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Conservative surgery for borderline ovarian tumors: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Borderline epithelial tumors of the ovary

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Clinical management potential tumours of low malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Surgical staging in patients with ovarian tumors of low malignant potential

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Symposium: ovarian tumors of borderline malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Borderline tumors of the ovary.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Ovarian serous borderline tumors with invasive peritoneal implants

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4843123

Serous borderline tumours of the ovary

5 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Micropapillary serous ovarian carcinoma: surgical management and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Laparoscopic management of borderline ovarian tumors: results of a French multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Use of tumour markers in monitoring the course of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Evaluation of serum CA 125 level as a tumor marker in borderline tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.11.016

Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21146201

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2010.11.016

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

21146201

1 reference